NBA to Let Players Invest in Cannabis Industry and Promote Brands with New Deal
The NBA is giving players the option to invest in the cannabis industry under a new deal.
Cannabis is officially being removed from the National Basketball Association’s (NBA) banned substances list for players. Another slam dunk for cannabis is that the association plans to let those players promote and invest in cannabis companies (1).
The new seven-year agreement also plans to formally remove drug testing requirements for cannabis. For the past three seasons, the NBA has considered the testing requirement to be temporarily suspended.
“We decided that, given all the things that were happening in society, given all the pressures and stress that players were under, that we didn’t need to act as Big Brother right now,” Adam Silver, NBA Commissioner, commented on in the past. “I think society’s views around marijuana has changed to a certain extent.”
Details about the Collective Bargaining Agreement between the NBA and National Basketball Players Association will not be released until a term sheet is finalized.
Reference
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
